PreveCeutical Engages New to the Street for Production & Broadcasting Services
- None.
- None.
NTTS has agreed to accept the following compensation in exchange for performing the Services: The Client agrees to pay New to the Street Group LLC
- Develop a biography-format interview series at NYC or Via Zoom outlining the announced milestones of PreveCeutical
- 4x Bloomberg Broadcasts (Bloomberg TV as Sponsored Programming)
- 3x Newsmax Broadcasts
- 10x FOX Business Broadcasts
- 10 (30-sec) & 15 (15-sec) Commercials per month- Fox Business, Bloomberg, Newsmax, Twitter, Instagram
- 6x Months of New To The Street Social Media Support
- 2 Special Reports that will feature PreveCeutical during local morning and evening television news shows. (Network News Pickups. ABC, NBC, CBS etc.)
- New To The Street Podcast on Spotify and Apple Music
- Monthly Strategy calls with the NTTS team
NTTS is located at 99 W Hawthorne Ave, Suite 300,
PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products. The Company aims to be a leader in the preventive health sciences sector.
With the completion of three of its research programs, the Company is actively working on the development, clinical trials, and commercialization of its products; and has filed a number of provisional patent applications to protect the intellectual property from its research programs.
For more information about PreveCeutical, please visit our website, www.PreveCeutical.com or follow us on Twitter and Facebook.
On behalf of the Board of Directors of PreveCeutical
Stephen Van Deventer, Chairman and Chief Executive Officer
This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian and
Actual results could differ from those projected in any forward-looking statements due to numerous factors including, risks and uncertainties relating to the Analgesic Program, complexities and delays in connection with research and development activities and the actual results of research and development activities, and the inability of the Company, to, among other things, obtain any required governmental, regulatory or stock exchange approvals, permits, consents or authorizations required, including Canadian Securities Exchange acceptance of any planned future activities, commercialize therapeutic and diagnostic technologies, execute its proposed business plans, pursue business partnerships, complete its research and product development programs as planned, including the Analgesic Program, and obtain the financing required to carry out its planned future activities. Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the healthcare and cannabis industries in
Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/preveceutical-engages-new-to-the-street-for-production--broadcasting-services-301914295.html
SOURCE PreveCeutical Medical Inc
FAQ
What is the Service Agreement between PreveCeutical Medical Inc. and New to the Street Group LLC about?
What is the compensation for New to the Street Group LLC for performing the Services?
What is the duration of the Agreement?